Pharmacology In — Drug Discovery And Development |top|

The journey from a molecular concept to a life-saving medication is a complex, costly, and time-intensive process, largely driven by the science of . Pharmacology in drug discovery and development forms the foundational bridge connecting basic biological research with clinical therapeutic application. It is the systematic study of how chemical agents interact with living systems, encompassing the identification of drug targets, the evaluation of safety and efficacy, and the determination of optimal dosing regimens [5.2, 5.3].

Phase 1 is a pure pharmacology study. It is not about efficacy; it is about safety and human PK/PD.

What the drug does to the body. PD describes the drug's mechanism of action—the specific interaction with a receptor, enzyme, or ion channel. It quantifies the relationship between drug concentration at the site of action and the resulting pharmacological effect. Key PD concepts include affinity (the tendency to bind), efficacy (the ability to produce an effect), and potency (the concentration required to produce half the maximal effect, or EC50). pharmacology in drug discovery and development

1. The Core Disciplines: Pharmacodynamics and Pharmacokinetics

The future of pharmacology lies in the integration of computational modeling. is an emerging approach that combines computer modeling with pharmacology to simulate drug action within biological systems. The journey from a molecular concept to a

Understanding the relationship between drug concentration and its biological effect is essential for successful drug development. Pharmacokinetics (PK):

Perhaps the most significant shift is the integration of artificial intelligence (AI). AI is no longer a futuristic concept but a tangible force reshaping drug discovery. In early 2020, virtually no AI-designed drugs had entered human trials; by mid-2025, dozens had reached clinical testing. AI and machine learning are being deployed across the drug discovery landscape. They are being used to: Phase 1 is a pure pharmacology study

Pharmacologists work to understand the underlying mechanisms of diseases to identify molecular targets, such as enzymes, receptors, or signaling pathways, which can be modified by a drug [5.2]. Target validation involves establishing that manipulating a specific target indeed produces a therapeutic effect. Screening and Optimization

What the body does to the drug. PK describes the journey of the drug through the body over time, summarized by the acronym ADME :